Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
Jump to section
Related Articles
Cited By...
- Cangrelor versus GPIIb/IIIa inhibitors as adjunctive therapy in endovascular treatment of large vessel occlusion stroke
- Safety and efficacy of cangrelor in endovascular thrombectomy compared with glycoprotein IIb/IIIa Inhibitors
- Cangrelor for emergent carotid stenting during stroke thrombectomy: a comparative analysis versus glycoprotein IIb/IIIa inhibitors or aspirin monotherapy
- The Safety and Efficacy of Cangrelor in Endovascular Thrombectomy Compared with Glycoprotein IIb/IIIa Inhibitors
- Rescue intracranial permanent stenting for refractory occlusion following thrombectomy: a propensity matched analysis
- Efficacy and safety of low dose intravenous cangrelor in a consecutive cohort of patients undergoing neuroendovascular procedures
- Comparison of three antithrombotic strategies for emergent carotid stenting during stroke thrombectomy: a multicenter study
- Rescue intracranial permanent stenting for refractory occlusion following thrombectomy: a propensity matched analysis
- Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey
- Safety and Efficacy of Cangrelor in Acute Stroke Treated with Mechanical Thrombectomy: Endovascular Treatment of Ischemic Stroke Registry and Meta-analysis